AI Models to Predict Thyroid Cartilage Invasion in Laryngeal Carcinoma
Launched by FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY · Jun 17, 2024
Trial Information
Current as of September 10, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how artificial intelligence (AI) can help doctors predict whether laryngeal cancer has invaded the thyroid cartilage, which is an important structure in the neck. By using CT scans, the researchers aim to create a model that provides more accurate information before surgery, helping doctors make better treatment decisions. They are also looking at how well this model can predict patient survival outcomes.
To participate in the trial, individuals should be between 65 and 84 years old and need to have a confirmed diagnosis of laryngeal squamous cell carcinoma, either through surgery or a biopsy. They must also have had a CT scan within two weeks before their surgery. However, patients who have received chemotherapy or radiation therapy before the surgery, those with certain issues in their CT images, or those whose cancer has returned will not be eligible. If you join this study, you can expect to contribute to important research that could improve the way laryngeal cancer is diagnosed and treated in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Availability of complete clinical data
- • 2. Surgery-proven or biopsy-proven diagnosis of laryngeal squamous cell carcinoma
- • 3. CT examination performed within 2 weeks before surgery
- Exclusion Criteria:
- • 1. Patients who received preoperative chemotherapy or radiation therapy
- • 2. CT images with significant artifacts
- • 3. Patients with tumor recurrence
About First Affiliated Hospital Of Chongqing Medical University
The First Affiliated Hospital of Chongqing Medical University is a leading academic medical center dedicated to advancing healthcare through innovative clinical research and education. As a prominent sponsor of clinical trials, the hospital is committed to conducting high-quality, ethically-driven studies that contribute to the understanding and treatment of various medical conditions. With a robust infrastructure and a team of experienced researchers and healthcare professionals, the institution fosters collaboration across disciplines to enhance patient care and improve health outcomes. Its strategic focus on translational medicine underscores the hospital's role in bridging the gap between laboratory discoveries and clinical applications, ultimately benefiting patients and the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chongqing, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported